Hubei Biocause Pharmaceutical (000627) - Total Liabilities

Latest as of September 2024: CN¥249.15 Billion CNY ≈ $36.46 Billion USD

Based on the latest financial reports, Hubei Biocause Pharmaceutical (000627) has total liabilities worth CN¥249.15 Billion CNY (≈ $36.46 Billion USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 000627 cash flow conversion to assess how effectively this company generates cash.

Hubei Biocause Pharmaceutical - Total Liabilities Trend (2000–2023)

This chart illustrates how Hubei Biocause Pharmaceutical's total liabilities have evolved over time, based on quarterly financial data. Check 000627 financial resilience to evaluate the company's liquid asset resilience ratio.

Hubei Biocause Pharmaceutical Competitors by Total Liabilities

The table below lists competitors of Hubei Biocause Pharmaceutical ranked by their total liabilities.

Company	Country	Total Liabilities
Atresmedia Corporación de Medios de Comunicación S.A. MC:A3M	Spain	€745.49 Million
CONMED Corporation NYSE:CNMD	USA	$1.29 Billion
Hangzhou Greenda Electronic Materials Co Ltd SHG:603931	China	CN¥146.37 Million
China Reform Health Management and Services Group Co Ltd SHE:000503	China	CN¥744.82 Million
Decai Decoration Co Ltd SHG:605287	China	CN¥9.25 Billion
Kumho Tire KO:073240	Korea	₩3.30 Trillion

Liability Composition Analysis (2000–2023)

This chart breaks down Hubei Biocause Pharmaceutical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hubei Biocause Pharmaceutical market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	11.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.87	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hubei Biocause Pharmaceutical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hubei Biocause Pharmaceutical (2000–2023)

The table below shows the annual total liabilities of Hubei Biocause Pharmaceutical from 2000 to 2023.

Year	Total Liabilities	Change
2023-12-31	CN¥268.30 Billion ≈ $39.26 Billion	+5.63%
2022-12-31	CN¥254.00 Billion ≈ $37.17 Billion	+12.17%
2021-12-31	CN¥226.43 Billion ≈ $33.13 Billion	+10.55%
2020-12-31	CN¥204.81 Billion ≈ $29.97 Billion	+19.83%
2019-12-31	CN¥170.92 Billion ≈ $25.01 Billion	+12.27%
2018-12-31	CN¥152.24 Billion ≈ $22.28 Billion	+33.88%
2017-12-31	CN¥113.71 Billion ≈ $16.64 Billion	+16.65%
2016-12-31	CN¥97.48 Billion ≈ $14.26 Billion	+15484.25%
2015-12-31	CN¥625.50 Million ≈ $91.53 Million	+1.09%
2014-12-31	CN¥618.76 Million ≈ $90.54 Million	-14.15%
2013-12-31	CN¥720.71 Million ≈ $105.46 Million	+36.66%
2012-12-31	CN¥527.37 Million ≈ $77.17 Million	+12.33%
2011-12-31	CN¥469.47 Million ≈ $68.70 Million	+25.44%
2010-12-31	CN¥374.25 Million ≈ $54.76 Million	-35.62%
2009-12-31	CN¥581.29 Million ≈ $85.06 Million	+24.54%
2008-12-31	CN¥466.75 Million ≈ $68.30 Million	+1.80%
2007-12-31	CN¥458.52 Million ≈ $67.10 Million	+3.35%
2006-12-31	CN¥443.66 Million ≈ $64.92 Million	+24.38%
2005-12-31	CN¥356.70 Million ≈ $52.20 Million	-0.20%
2004-12-31	CN¥357.41 Million ≈ $52.30 Million	-3.98%
2003-12-31	CN¥372.22 Million ≈ $54.47 Million	+15.46%
2002-12-31	CN¥322.39 Million ≈ $47.18 Million	+42.59%
2001-12-31	CN¥226.09 Million ≈ $33.08 Million	-22.52%
2000-12-31	CN¥291.81 Million ≈ $42.70 Million	--

About Hubei Biocause Pharmaceutical

SHE:000627 China Insurance - Life

Market Cap

$1.13 Billion

CN¥7.75 Billion CNY

Market Cap Rank

#8572 Global

#2236 in China

Share Price

CN¥1.58

Change (1 day)

+0.00%

52-Week Range

CN¥1.39 - CN¥2.74

All Time High

CN¥10.45